We previously demonstrated the cAMP-PKA pathway to be associated with the reduction in aggregated proteins such as immune complex in glomeruli. The aim of this study was to clarify whether PKC is involved in the reduction of aggregated protein and phosphorylation of CREB in aggregated protein-loaded glomeruli. Mice were injected with aggregated bovine serum albumin (a-BSA), and glomeruli were isolated. The a-BSA-injected mice produced more cyclic AMP and had more phosphorylated serine and phosphorylated CREB in their glomeruli than the controls. The expression of phospho-CREB increased with the accumulation of a-BSA. KT5720 and H7 suppressed the increase in phosphorylated CREB in a-BSA-loaded glomeruli and the decrease in accumulated a-BSA in the glomeruli. These findings suggest that PKC is associated with the reduction of aggregated protein and phosphorylation of CREB in aggregated protein-loaded glomeruli.
Introduction
immune complex (iC) accumulates in the glomerular capillary wall and mesangial area in nephritic patients. iC is associated with the development of glomerulonephritis through the activation of complements and the infiltration of neutrophils and monocytes into glomeruli [1, 2] .
we previously demonstrated that prostaglandin e 2 and 8-bromo cyclic amP accelerate the clearance of aggregated protein from glomeruli, acting through protein kinase a [6] . The prostaglandin e 2 receptor (eP) has a 7-transmembrane structure, and eP2 and eP4 are coupled to the gs protein [8, 13] . The glomeruli express mrNa of eP2 and eP4 [6] , produce prostaglandin e 2 , and generate cyclic amP in response to prostaglandin e 2 [12] . wo et al. reported that protein kinase C (PKC) mediated increases in the phosphorylation of cyclic amP response element binding protein (CreB) in the spinal cord of rats following an injection of capsaicin [15] . Furthermore, hexosamine induced production of the fibronectin in cultured rat mesangial cells followed by increases in the phosphorylation of CreB, and a pharmacologic inhibitor of protein kinase a and protein kinase C blocked the phosphorylation of CREB and fibronectin synthesis induced by a high concentration of glucose [12] . Therefore, we attempted to clarify whether PKC is associated with the reduction in the amount of aggregated proteins and with phosphorylation of CreB in glomeruli in which aggregated proteins are accumulated. 
Materials and Methods

Animals
male iCr mice (Charles river Laboratories Japan, Yokohama, Japan), weighing about 25 g, were housed in an air-conditioned room at 22°C with a 12-h light-dark cycle during the experimental period. all experiments were performed in accordance with the guiding Principles for the Care and use of Laboratory animals approved by the Japanese Pharmacological society, and the National institutes of Health guide for the Care and use of Laboratory animals.
Materials
igePaL Ca-630, Protease inhibitor Cocktail, rabbit anti-CreB antibody, rabbit anti-phospho-CreB (ser133) antibody, peroxidase-conjugated anti-mouse immunoglobulin g antibody, biotin-conjugated monoclonal anti-phosphoserine antibody (clone Psr-45), biotinconjugated monoclonal anti-phosphothreonine antibody (clone PTr-8), anti-bovine serum albumin monoclonal antibody (Bsa-133), KT5720, H7, iBmX, iron oxide, and rPmi 1640 medium were purchased from sigmaaldrich (st. Louis, mo, usa); crystallized bovine serum albumin was purchased from serologicals Proteins (Kankakee, iL, usa); Hybond eCL Nitrocellulose membrane ® and eCL western Blotting Detection reagents ® were purchased from amersham Pharmacia Biotech (Piscataway, NJ, usa); DC Protein assay ® kits, 30% acrylamide/bis solution and 2-β mercaptoethanol were purchased from Bio-rad Laboratories (Hercules, Ca, usa); immunocatcher ® was purchased from Cytosignal research Products (irvine, Ca, usa); horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin g antibody and horseradish peroxidase-conjugated streptavidin were purchased from Vector Laboratories (Burlingame, Ca, usa); aBTs Peroxidase substrate system ® kits and Peroxidase stop solution ® were purchased from KPL (gaithersburg, mD, usa); streptavidin-conjugated horseradish peroxidase was purchased from Zymed Laboratories (san Francisco, Ca, usa); sea Block Blocking reagent ® was purchased from Pierce (rockford, iL, usa); and sodium dodecyl sulfate, ammonium peroxodisulfate, N,N,N',N'-tetramethylethylenediamine and polyoxyethylene sorbitan monolaurate were purchased from wako Pure Chemical (osaka, Japan).
Preparation of aggregated bovine serum albumin
aggregated bovine serum albumin (a-Bsa) was prepared as reported previously [4] . Briefly, crystallized bovine albumin was dissolved in saline at a concentration of 30 mg/ml. The solution was alkalinized (pH 10) with 0.2 m NaoH and then incubated at 70°C for 20 min and at 79°C for 15 min. after cooling at room temperature, the solution was neutralized with 0.2 m HCl, and centrifuged at 810 × g for 30 min. The supernatant was stored in a freezer prior to use.
Isolation of glomeruli
mice were injected with 0.8 mg of a-Bsa/g body weight at 0 and 3 h. The kidneys were perfused with phosphate buffered saline (PBs) containing iron oxide particles (1 mg/ml PBs) via the abdominal aorta 6 h after the first injection of a-BSA and then removed and minced. The glomeruli were isolated with two kinds of nylon mesh (90-and 38-mm) and a magnet [7] . The purity of the glomeruli was more than 95% as observed under a light microscope.
Determination of cyclic AMP
glomeruli were suspended in serum-free rPmi 1640 medium containing 1 × 10 −5 m iBmX at 5,000 glomeruli/ml and incubated for 30 min at 37°C in a Co 2 incubator. after the incubation, 500 μl of ice-cold 10% trichloroacetic acid was added to the medium, and the glomeruli were disrupted by sonication at 4°C for 15 min twice. The supernatant was separated by centrifugation at 4°C and 5,000 rpm for 20 min, and cyclic amP was determined using an immunoassay system (ge Healthcare Bioscience, Tokyo, Japan) according to the manufacturer's instructions.
Immunoprecipitation and immunoblotting of phospho-CREB
glomeruli were suspended in PBs at 20,000 glomeruli/ml. The glomeruli were transferred to sonication tubes containing 900 μl of lysis buffer (150 mm NaCl, 0.2 m eDTa, and 0.02 m Tris-HCl pH 6.9), 100 μl of protease inhibitor cocktail, and 10 μl of igePaL Ca-630, disrupted by sonication, and centrifuged at 12,000 rpm for 10 min at 4°C. The amount of protein in the supernatant was determined by a direct assay using a DC protein assay kit (Bio-rad Japan, Tokyo, Japan). CreB was precipitated with a combination of the anti-CreB antibody (1:250) and protein a/g resin according to the manufacturer's directions (immunocatcher ® ). samples (3 μl) were subjected to electrophoresis in 10% acrylamide gels, and the proteins were transferred to nitrocellulose membranes. The membranes were subjected to immunoblotting as reported previously [6] . Total (phosphorylated and nonphosphorylated) CreB was detected with the anti-CreB antibody (1:1,000). Phosphorylatedserine (phospho-serine) and phosphorylated CreB (phospho-CreB) were detected using antibodies (1:5,000). The immunoreactive bands were revealed after incubation with the appropriate horseradish peroxidase-conjugated secondary antibody followed by a chemiluminescence reaction with the eCL western Blotting Detection reagents. The relative amount of immunoreactive protein in each band was determined by NiH image.
Determination of a-BSA in glomeruli
glomeruli were suspended in PBs at 3,000 glomeruli/ml and disrupted by sonication. one hundred microliters of sample was adsorbed in each well of a 96-well immunoplate (Nunc, a/s, Denmark) at 37°C for 60 min. after three washes with 0.05% PBs-T, each well was blocked with 200 μl of 0.1% sea BLoCK ® -PBs at 37°C for 30 min. Following further washing, 100 μl of the anti-Bsa antibody (1:500) was added, and the plate was placed at 4°C overnight. Next, 100 μl of biotin-conjugated goat anti-mouse immunoglobulin g (1:1,000) was added, and the plate was incubated at 37°C for 60 min. after more washing, 100 μl of horseradish peroxidaseconjugated streptavidin was added, the plate was placed at room temperature for 20 min, and the reaction was stopped with 100 μl of peroxidase stop solution. optical density was determined with a microplate reader (Biorad Laboratories) at 405 nm.
Statistical analyses
results are expressed as the mean ± sem. The data were subjected to a one-way analysis of variance (aNoVa) or the Kruskal-wallis test. analyses for statistical significance were carried out with the Student's t-test. To determine the significance of differences among groups, Bonferroni's procedure was used. Differences between the mean values of the experimental and control groups were considered significant at P<0.05.
Results
Production of cyclic AMP and phosphorylation of CREB in a-BSA-loaded glomeruli
glomeruli were isolated 6 h after the injection of aggregated bovine serum albumin (a-Bsa). The glomeruli were incubated for 30 min in the presence of iBmX. Control glomeruli isolated from the kidneys of vehicleinjected mice produced 8.4 pmol/ml of cyclic amP. aBsa-loaded glomeruli produced 42.3 pmol/ml of cyclic amP (Fig. 1a) . CreB was precipitated with the antiCreB antibody, and the expression of phospho-serine, phospho-threonine and phospho-CreB was analyzed by immunoblotting. as shown in Fig. 1B and 1C , CreB phosphorylated at serine 133 (phospho-CreB) was detected in the glomeruli isolated from a-Bsa-injected mice 6 h after the first injection of a-BSA. A-BSAloaded glomeruli exhibited increased expression of phospho-serine, 1.7 times that of glomeruli from vehicleinjected mice (Fig. 1B and 1C) . a-Bsa also caused a 2.3-fold increase in phospho-CreB in the glomeruli (Fig. 1B and 1C) .
Involvement of PKA in reduction of a-BSA and phosphorylation of CREB
We isolated glomeruli 6 h after the first injection of a-Bsa and incubated them with KT5720, a PKa inhibitor, for 3 h. The amount of a-Bsa in the glomeruli had diminished 63% after the 3-h-incubation. in the presence of KT5720, the decrease in a-Bsa was inhibited in a dose-dependent manner (Fig. 2a) . The amount of a-Bsa in the glomeruli treated with 10 −5 m KT5720 was equivalent to that at 0 h. as shown in Fig. 2B and 2C, the a-Bsa-induced phosphorylation of CreB was dose-dependently suppressed by KT5720. The phosphorylation of CreB was completely suppressed in the presence of 10 −5 m KT5720.
Involvement of PKC in phosphorylation of CREB and reduction of a-BSA
glomeruli were isolated 6 h after the injection of aBsa, and then incubated with H7, a PKC inhibitor, for 3 h. The amount of a-Bsa in the vehicle-treated glomeruli was 57% of that before the incubation. when the a-Bsa-loaded glomeruli were treated with 10 −5 m H7, the decrease in a-Bsa was inhibited; that is, the amount of a-Bsa-loaded glomeruli was 70% of that before the treatment (Fig. 3a) . as shown in Fig. 3B and 3C , the a-Bsa-induced phosphorylation of CreB was dosedependently suppressed by the treatment with H7: 1.75-fold with vehicle, 1.25-fold with 10 −7 m H7, and 1.0-fold with 10 −6 m H7.
Discussion
in the present study, pharmacological experiments were carried out to define the association of PKA and PKC with the phosphorylation of CreB and with the reduction in the amount of aggregated protein in glomeruli. we found that aggregated protein increased the levels of phospho-serine and phospho-CreB. a PKa inhibitor and a PKC inhibitor blocked the decrease in the amount of aggregated protein. Both inhibitors attenuated the a-Bsa-induced increase in phospho-CreB. The amount of a-Bsa in the lysate of glomeruli was determined by eLisa with anti-Bsa antibody as described in the "methods." (B, C) western blotting of phospho-CreB. immunoprecipitation was performed with lysate of glomeruli and anti-CreB antibody (CreB). immunoblotting was performed with anti-phospho-CreB antibody (p-CreB). The density of the bands was determined by NiH-image. The results are expressed as the mean ± sem. (a, n=5; B, n=4). # and ## : P <0.05 and P <0.01 compared with the "0 h" group, respectively. * and **: P <0.05 and P <0.01 compared with the "Vehicle" group, respectively. Fig. 1 . aggregated protein increases the levels of cyclic amP (camP) and phosphorylated CreB in glomeruli. mice were injected with a-Bsa (0.8 mg/g body weight) at 0 and 3 h. The glomeruli were isolated 6 h after the first injection. (A) cAMP was measured as described in the "Methods." (B, C) western blotting of phospo-CreB. immunoprecipitation was performed with lysate of glomeruli and anti-CreB antibody. immunoblotting was performed with anti-CreB antibody (CreB), anti-phosphoserine antibody (p-serine), anti-phosphothreonine antibody (p-Threonine), or anti-phospho-CreB antibody (p-CreB). The density of the bands was measured by NiHimage. results are expressed as the mean ± sem. (a, n=5; B, n=4). * and **: P <0.05 and P <0.01 compared with the "a-Bsa" group, respectively.
These results suggest that PKa and PKC are associated with the reduction in the amount of aggregated protein and phosphorylation of CreB in a-Bsa-loaded glomeruli. KT5720 is a specific PKA inhibitor, and its IC 50 is 5 × 10 −8 m. in the present study, 1 × 10 −7 of KT5720 failed to exert any inhibitory effects on either phosphorylation of CreB or reduction in the amount of a-Bsa in a-Bsaloaded glomeruli, although KT5720 suppressed them to a significant degree at 1 × 10 −5 m, which is 200 times the concentration of its iC 50 . The findings strongly suggest that PKa is rarely involved in such outcomes. on the other hand, we used H7 as an inhibitor of PKC. while H7 has an inhibitory effect on PKa as well as on PKC, it has an iC 50 of 6 × 10 −6 m on PKC. in the present study, H7 exerted a significant suppressive effect on phosphorylation of CreB at 1 × 10 −6 m and the reduction in the amount of a-Bsa at 1 × 10 −5 m. Taken together, it is likely that PKC participates in phosphorylation of CreB by a-Bsa and in the reduction of a-Bsa. Further studies are needed to clarify the involvement of PKC in the reduction of aggregated protein in the glomeruli; such studies would need to employ more specific inhibitors of PKC and selective inhibitors of subtypes of PKC.
intriguingly, the PKC inhibitor attenuated the phosphorylation of CreB in a-Bsa-loaded glomeruli. we expected the inhibitor of PKa, not PKC, to suppress the phosphorylation, having demonstrated that a-Bsa activated the cyclic amP-PKa system in isolated glomeruli using pharmacological manipulations [6] . other investigators have clarified the ability of isolated glomeruli and mesangial cells to accumulate camP in response to various agonists [10, 11] . singh et al. demonstrated that a high concentration of glucose (25 mmol/l) increased the production of fibronectin and phosphorylation of CreB in sV40-transformed rat mesangial cells, both of which were attenuated by pharmacological inhibitors of PKa and PKC [12] . we previously reported a remarkable accumulation of a-Bsa in the glomeruli of diabetic mice [4] . moreover, PKC induced CreB phosphorylation in cultured rat strial neurons stimulated with phorbol 12-myristate 13-acetate [3] . in area Ca1 of the rat hippocampus, the activation of maPK also caused CreB phosphorylation [9] . it was suggested that PKa and PKC induce the phosphorylation both directly and via a maPK signaling cascade [9] . Therefore, it is likely that aggregated proteins accelerate the phosphorylation of CreB through PKC in glomeruli.
Prostaglandin e 2 stimulates production of cyclic amP via eP2 and eP4 prostaglandin e receptors in isolated glomeruli [6, 7, 14] . we have demonstrated that isolated glomeruli generate prostaglandin e 2 and that a-Bsa increases the expression of cyclooxygenase-2 mrNa and cyclooxygenase-2 activity followed by the expression of prostaglandin e 2 [5] . Phagocytosis of zymosan particles by Kupffer cells is accompanied by the production of prostaglandin e 2 and cyclic amP [16] . Therefore, it is conceivable that a-Bsa causes an increase in cyclic amP following the augmentation of prostaglandin e 2 production, and an increase in the phosphorylation of CreB. although we did not demonstrate how a-Bsa induced the activation of PKC by a-Bsa, other receptors of prostaglandin e, eP1 receptors, could be involved. Further investigation is needed to clarify this issue.
